We thus evaluated the appearance of palpable tumors and observed that Δ16HER2/EMI1 KO female mice exhibited a significantly earlier tumor onset compared to the WT counterpart (13.32 vs 15.28 weeks) (Fig. 4a). Here, FBXO5 is linked to neoplasm.